Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma
- PMID: 11895909
Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma
Abstract
Purpose: Methylthioadenosine phosphorylase (MTAP) is an enzyme essential in the salvage of cellular adenine and methionine synthesis. The MTAP gene is located in the 9p21 chromosomal region and its loss is frequently associated with deletion of the tumor suppressor genes p15(INK4b) and p16(INK4a). The aim of this study was to investigate the frequency of molecular alterations in MTAP in osteosarcoma.
Experimental design: Samples from patients with high-grade osteosarcoma (n = 96) and three osteosarcoma cell lines (HOS, SaOS-2, and U2OS) were analyzed. Genomic DNA was analyzed for MTAP gene deletions by PCR, RNA expression was measured by semiquantitative reverse transcription-PCR, and the protein levels were measured by immunohistochemistry.
Result: Deletion of at least one MTAP exon was found in 36 of 96 (37.5%) osteosarcoma patient samples and in one of the three cell lines (HOS). In all cases in which an MTAP gene deletion was observed, there was absence of detectable mRNA and protein. Furthermore, in four osteosarcoma patients, an MTAP deletion which was not evident at diagnosis was detected in subsequent tumor samples.
Conclusions: The MTAP gene is commonly deleted in osteosarcoma patient samples, leading to an absence of mRNA and protein expression; these results indicate that inhibitors of de novo purine synthesis or methionine depletion may be effective as treatments for osteosarcoma patients whose tumors fail to express MTAP.
Similar articles
-
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):409-15. doi: 10.1001/archotol.132.4.409. Arch Otolaryngol Head Neck Surg. 2006. PMID: 16618910
-
CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2003 May;37(1):44-57. doi: 10.1002/gcc.10188. Genes Chromosomes Cancer. 2003. PMID: 12661005
-
Methylthioadenosine phosphorylase deficiency in Japanese osteosarcoma patients.Int J Oncol. 2007 Nov;31(5):1069-76. Int J Oncol. 2007. PMID: 17912432
-
Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.Genes Chromosomes Cancer. 1998 May;22(1):72-8. Genes Chromosomes Cancer. 1998. PMID: 9591637 Review.
-
[Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].Bull Cancer. 1998 Sep;85(9):747-54. Bull Cancer. 1998. PMID: 9817058 Review. French.
Cited by
-
Origin and Therapies of Osteosarcoma.Cancers (Basel). 2022 Jul 19;14(14):3503. doi: 10.3390/cancers14143503. Cancers (Basel). 2022. PMID: 35884563 Free PMC article. Review.
-
Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.PLoS One. 2009 May 29;4(5):e5735. doi: 10.1371/journal.pone.0005735. PLoS One. 2009. PMID: 19478948 Free PMC article.
-
S-adenosylmethionine as a biomarker for the early detection of lung cancer.Chest. 2007 Oct;132(4):1247-52. doi: 10.1378/chest.07-0622. Chest. 2007. PMID: 17934114 Free PMC article.
-
Magnetic-Driven Hydrogel Microrobots Selectively Enhance Synthetic Lethality in MTAP-Deleted Osteosarcoma.Front Bioeng Biotechnol. 2022 Jul 6;10:911455. doi: 10.3389/fbioe.2022.911455. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35875497 Free PMC article.
-
Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.PLoS Pathog. 2009 Jun;5(6):e1000492. doi: 10.1371/journal.ppat.1000492. Epub 2009 Jun 26. PLoS Pathog. 2009. PMID: 19557159 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases